Stereotaxis (STXS) Other Non-Current Liabilities (2010 - 2026)
Stereotaxis (STXS) reported Other Non-Current Liabilities of $5.1 million for Q1 2026, up 7881.25% year-over-year from $64000.0 in Q1 2025, and up 365.63% quarter-over-quarter from $1.1 million in Q4 2025.
Stereotaxis (STXS) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has 17 years of Other Non-Current Liabilities data on file, last reported at $5.1 million in Q1 2026.
- Other Non-Current Liabilities for Q1 2026 came in at $5.1 million, up 7881.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.1 million (up 7881.25% YoY), and the FY2025 annual result was $1.1 million, up 1614.06% from the prior year.
- Other Non-Current Liabilities improved to $5.1 million in Q1 2026 per STXS's latest filing, from $1.1 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $6.4 million in Q2 2025 and troughed at $43000.0 in Q2 2023.
- A 5-year average of $868941.2 and a median of $64000.0 in 2024 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2023 and 2025: Other Non-Current Liabilities sank 78.71% in 2023, then surged 11722.22% in 2025.
- A 5-year view of Other Non-Current Liabilities shows it stood at $51000.0 in 2022, then fell by 15.69% to $43000.0 in 2023, then surged by 48.84% to $64000.0 in 2024, then jumped by 1614.06% to $1.1 million in 2025, then jumped by 365.63% to $5.1 million in 2026.
- Business Quant data shows STXS's Other Non-Current Liabilities at $5.1 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Stereotaxis | 180.48 Mn | 165.86 Mn | 3.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.11 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | 6.38 Mn |
| Mar 31, 2025 | 64,000.00 |
| Dec 31, 2024 | 64,000.00 |
| Sep 30, 2024 | 55,000.00 |
| Jun 30, 2024 | 54,000.00 |
| Mar 31, 2024 | 43,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Sep 30, 2023 | 43,000.00 |
| Jun 30, 2023 | 43,000.00 |
| Mar 31, 2023 | 51,000.00 |
| Dec 31, 2022 | 51,000.00 |
| Sep 30, 2022 | 168,000.00 |
| Jun 30, 2022 | 202,000.00 |
| Mar 31, 2022 | 202,000.00 |
| Dec 31, 2021 | 218,000.00 |
| Sep 30, 2021 | 215,861.00 |
| Jun 30, 2021 | 206,596.00 |